Evidence map›Paper›PMID 26267430›Full record

ArticlePloS one2015

Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013.

Jens W Levy, Sriluck Simasathien, Veerachai Watanaveeradej, Piraya Bhoomiboonchoo, Stefan Fernandez, Richard G Jarman, Chonticha Klungthong, Robert V Gibbons, Phirangkool Kerdpanich, Danaband Piboonbanakit and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Jens W LevyDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Sriluck SimasathienPhramongkutklao Hospital, Bangkok, Thailand.
Veerachai WatanaveeradejPhramongkutklao Hospital, Bangkok, Thailand.
Piraya BhoomiboonchooDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Stefan FernandezDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Richard G JarmanViral Disease Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Chonticha KlungthongDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Robert V GibbonsDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Phirangkool KerdpanichPhramongkutklao Hospital, Bangkok, Thailand.
Danaband PiboonbanakitPhramongkutklao Hospital, Bangkok, Thailand.
Tundorn ChirabandhuPhramongkutklao Hospital, Bangkok, Thailand.
In-Kyu YoonDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Armed Forces Research Institute of Medical Science · THPhramongkutklao Hospital · THWalter Reed Army Institute of Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza in the tropics occurs year round with peaks that correspond variably to temperate regions. However, data on influenza vaccine effectiveness (VE) in the tropics is sparse. We report on the effectiveness of influenza vaccine to prevent medically attended laboratory confirmed influenza from sentinel surveillance conducted at a Thai military medical facility in Bangkok, Thailand from August 2009 to January 2013. Patients ≥6 months old presenting with influenza-like illness underwent combined nasal/throat swabs which were tested by influenza RT-PCR. A case test-negative study design was used to evaluate VE. Of 2999 samples available for analysis,1059 (35.3%) were PCR-positive (cases) and 1940 (64.6%) were PCR-negative (test-negative controls). Five hundred and seven (16.9%) of these patients reported being vaccinated within the previous 12 months. Periods of high and low influenza activity were defined based on publicly available Thai Ministry of Public Health data. Overall VE adjusted for age and epiweek was found to be 50.1% (95%CI: 35.0, 61.9%). The May to April adjusted VE for year 2010, 2011 and 2012 was 57.7% (95%CI: 33.7, 73.8%), 57.1% (95% CI: 35.2, 68.3%) and 37.6% (95% CI: 3.5, 62.9%).During high influenza activity in years with the same vaccine formulation, the adjusted VE was 54.9% (95%CI: 38.9, 66.9%). VE appeared to be much higher during high versus low influenza activity periods. The adjusted point estimate for VE was highest in the 18-49 year age group (76.6%) followed by 6-23 months (58.1%) and 2-17 years (52.5%). Adjusted estimates were not done for those ≥50 years of age due to small numbers. VE in patients with underlying disease was 75.5% compared to 48.0% in those without. Our findings demonstrate moderate protection by influenza vaccination and support the utility of influenza vaccination in the tropics including in very young children and those with underlying disease.

Indexed as

VaccinationAdolescentAdultChildChild, PreschoolFemaleHospitals, MilitaryHumansInfantInfant, NewbornInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza, HumanInfluenza VaccinesMaleMiddle AgedInfluenza Vaccines

Identifiers

PMID26267430
PMCPMC4534293
OpenAlexW1917134519

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.